Yan Yu

机构：Central South University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-5598-763X

发表论文 159 篇 · 总被引 3686 次 · h-index 28

代表论文

• Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 61)
• Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B) (2025 · Journal of Clinical Oncology · 被引 17)
• Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers (2025 · Signal Transduction and Targeted Therapy · 被引 13)
• Efficacy and safety of MHB088C, a novel B7-H3-targeted ADC, in patients with relapsed extensive-stage small cell lung cancer (ES-SCLC): Subgroup analysis from a phase 1/2 multicenter study. (2025 · Journal of Clinical Oncology · 被引 6)
• Integrating multi-omics to unveil PSMD12 as a critical gene in promoting brain metastases of lung adenocarcinoma (2025 · Journal of Translational Medicine · 被引 4)
• Real‐world effectiveness and safety of treatment strategies for unresectable, driver‐negative Stage III NSCLC : A retrospective multicentre study (2025 · International Journal of Cancer · 被引 2)